X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1929) 1929
Publication (103) 103
Newsletter (80) 80
Book Review (19) 19
Newspaper Article (19) 19
Magazine Article (9) 9
Book Chapter (4) 4
Transcript (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1252) 1252
male (1081) 1081
female (825) 825
parkinson disease - drug therapy (795) 795
levodopa - administration & dosage (695) 695
carbidopa - administration & dosage (661) 661
carbidopa (652) 652
middle aged (626) 626
aged (562) 562
levodopa - therapeutic use (544) 544
clinical neurology (542) 542
parkinson's disease (541) 541
carbidopa - therapeutic use (522) 522
index medicus (493) 493
animals (481) 481
levodopa (478) 478
drug combinations (449) 449
carbidopa - pharmacology (418) 418
adult (397) 397
antiparkinson agents - administration & dosage (377) 377
pharmacology & pharmacy (336) 336
levodopa - adverse effects (317) 317
dopa (312) 312
antiparkinson agents - therapeutic use (300) 300
drug therapy, combination (297) 297
neurosciences (277) 277
rats (272) 272
l-dopa (251) 251
levodopa - pharmacology (250) 250
carbidopa - adverse effects (236) 236
dose-response relationship, drug (224) 224
antiparkinson agents - adverse effects (208) 208
levodopa - pharmacokinetics (203) 203
dopamine (199) 199
motor fluctuations (191) 191
pharmacokinetics (178) 178
parkinsons-disease (176) 176
parkinson disease - physiopathology (169) 169
time factors (167) 167
treatment outcome (161) 161
double-blind method (155) 155
double-blind (147) 147
parkinsons disease (135) 135
levodopa - blood (128) 128
neurology (128) 128
antiparkinson agents - pharmacokinetics (127) 127
drug administration schedule (125) 125
administration, oral (119) 119
psychiatry (117) 117
carbidopa - pharmacokinetics (112) 112
delayed-action preparations (112) 112
dopamine - metabolism (110) 110
therapy (110) 110
entacapone (108) 108
drug therapy (103) 103
analysis (101) 101
dosage and administration (97) 97
research (93) 93
parkinson disease - blood (90) 90
aged, 80 and over (85) 85
adolescent (84) 84
mice (84) 84
drug interactions (83) 83
quality of life (81) 81
antiparkinson agents - pharmacology (80) 80
metabolism (80) 80
aromatic amino acid decarboxylase inhibitors (79) 79
care and treatment (76) 76
brain (75) 75
clinical trials as topic (72) 72
movement disorders (72) 72
parkinson disease - complications (72) 72
cross-over studies (70) 70
parkinson disease (70) 70
disease (69) 69
motor activity - drug effects (69) 69
rats, inbred strains (69) 69
brain - metabolism (68) 68
dyskinesia (67) 67
follow-up studies (66) 66
catechol o-methyltransferase inhibitors (64) 64
parkinson disease - diagnosis (64) 64
drug combinations - administration & dosage (61) 61
plasma (61) 61
severity of illness index (61) 61
catechol-o-methyltransferase (60) 60
dopamine - physiology (60) 60
neurologic examination - drug effects (60) 60
parkinson disease - metabolism (60) 60
clinical trials (59) 59
parkinson’s disease (58) 58
gels (57) 57
carbidopa - blood (56) 56
medicine & public health (56) 56
catechols - therapeutic use (55) 55
child (55) 55
corpus striatum - drug effects (55) 55
dopamine agents - therapeutic use (55) 55
dopamine agonists - therapeutic use (55) 55
carbidopa intestinal gel (54) 54
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1923) 1923
Russian (29) 29
Spanish (22) 22
German (16) 16
Japanese (11) 11
Hungarian (10) 10
French (7) 7
Polish (7) 7
Italian (5) 5
Chinese (3) 3
Dutch (3) 3
Arabic (1) 1
Hebrew (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of Neurology, ISSN 0364-5134, 07/2010, Volume 68, Issue 1, pp. 18 - 27
Journal Article
CLINICAL NEUROPHARMACOLOGY, ISSN 0362-5664, 07/2019, Volume 42, Issue 4, pp. 111 - 116
Objectives Although commercially available levodopa (LD) formulations include carbidopa (CD) or benserazide for gastrointestinal l-aromatic amino acid... 
levodopa | carbidopa | Parkinson disease | pharmacokinetics | PHARMACOLOGY & PHARMACY | STRIATUM | CLINICAL NEUROLOGY | PARKINSONS-DISEASE | Dosage and administration | Carbidopa | Dopa | Health aspects | Volunteers
Journal Article
Movement Disorders, ISSN 0885-3185, 04/2016, Volume 31, Issue 4, pp. 530 - 537
Journal Article
Journal Article
Journal of Neurology, ISSN 0340-5354, 11/2013, Volume 260, Issue 11, pp. 2701 - 2714
Journal Article
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 10/2012, Volume 83, Issue 10, pp. 1012 - 1014
Journal Article
Acta Neurologica Scandinavica, ISSN 0001-6314, 03/2016, Volume 133, Issue 3, pp. 208 - 215
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2014, Volume 13, Issue 2, pp. 141 - 149
Journal Article